Skip to content
CleaStart with Clea
Australia’s clearer way into migraine care.See how Clea works
Start with Clea
Migraine LibraryTreatments

Magnesium, riboflavin and CoQ10

Magnesium, riboflavin (vitamin B2) and coenzyme Q10 are commonly discussed nutraceutical options for migraine prevention.

About 2 min read · Australian context where available
Checking review recordSource references are available below.
KEY POINTS

The short version.

01

Evidence is variable but supportive for selected supplements

02

Supplements can still cause side effects or interactions

03

Pregnancy and kidney disease change the safety conversation

In this guide · 7 sections

Magnesium

Magnesium is one of the most commonly used migraine supplements and may be particularly relevant for some people with aura. Different formulations can have different gastrointestinal effects.

Riboflavin and CoQ10

Both have some evidence for prevention and are generally well tolerated, but they should still be discussed with a clinician or pharmacist if you take other medicines or have significant health conditions.

Where magnesium, riboflavin and coq10 fits

This Clea guide places magnesium, riboflavin and coq10 in the broader migraine treatment landscape. The important distinction is whether it is used for an attack, prevention, symptom support, rehabilitation or another specific care goal.

Treatment choice is individual. The role of a therapy depends on the migraine pattern, other health conditions, pregnancy or breastfeeding, interactions, previous treatment experience, access and a clinician's assessment.

Evidence and limitations

Clea separates evidence from popularity. Randomised trials, systematic reviews, guidelines, observational studies and patient experiences do not carry the same weight. Where evidence is limited or indirect, we say so rather than presenting uncertainty as a recommendation.

Australian access

Australian availability can involve TGA registration, prescription requirements, PBS restrictions, private access, specialist criteria or device availability. Those details can change, so Clea links to current official sources and keeps access separate from whether a treatment is clinically suitable for you.

Safety and suitability

Do not start, stop, combine or change a medicine because of a Clea page or a community experience. Side effects, contraindications and interactions need to be considered with a GP, neurologist or pharmacist who knows your medical history.

What to track in Clea

Record headache or migraine days, severity, associated symptoms, medicines used and the context around the episode. Several weeks of consistent observations are usually more useful than trying to prove a cause from one attack.

  • Headache and migraine-like days
  • Severity and function
  • Associated symptoms
  • Acute medicine days
  • Anything that changed around the pattern
SOURCES AND FURTHER READING

Go to the original sources.

Medicine and treatment information changes.

Clea checks source material, but PBS listings, medicine information and treatment access can change. Confirm current details with the TGA, PBS, your pharmacist or treating clinician.

How Clea sources and reviews migraine information →
KEEP EXPLORING

There is always more context.